相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer
Peng Zou et al.
CANCER LETTERS (2016)
Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells
Dongzhu Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
The relevance of EMT in breast cancer metastasis: Correlation or causality?
Ruben Bill et al.
FEBS LETTERS (2015)
Chronic Oxidative Stress Leads to Malignant Transformation Along With Acquisition of Stem Cell Characteristics, and Epithelial to Mesenchymal Transition in Human Renal Epithelial Cells
Prathap Kumar S. Mahalingaiah et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations
Andrii I. Rozhok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma
Yang Jiang et al.
ONCOTARGET (2015)
The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology
Emily S. Reisenbichler et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis
Hanqiu Zheng et al.
CANCER CELL (2014)
Selenium biochemistry and its role for human health
Marco Roman et al.
METALLOMICS (2014)
Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells
Prathap Kumar S. Mahalingaiah et al.
PLOS ONE (2014)
Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
Stefan Enroth et al.
NATURE COMMUNICATIONS (2014)
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Dler Faieeq Darweesh Mahmood et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Hydrogen Peroxide Promotes Epithelial to Mesenchymal Transition and Stemness in Human Malignant Mesothelioma Cells
Myung-Chul Kim et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis
Wei Yue et al.
STEROIDS (2013)
Thioredoxin System in Cell Death Progression
Jun Lu et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy
Jie He et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke et al.
CANCER CELL (2012)
Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis
Bradley A. Carlson et al.
CARCINOGENESIS (2012)
Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent
Lihui Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Thioredxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest
Jia-ning Fu et al.
INVESTIGATIONAL NEW DRUGS (2011)
Selenium and the Selenoprotein Thioredoxin Reductase in the Prevention, Treatment and Diagnostics of Cancer
Markus Selenius et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
Arne Holmgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets
Anton A. Turanov et al.
BIOCHEMICAL JOURNAL (2010)
Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors
Rita Yusuf et al.
CANCER CELL INTERNATIONAL (2010)
Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo
Qiang Tan et al.
INVESTIGATIONAL NEW DRUGS (2010)
Focus on mammalian thioredoxin reductases - Important selenoproteins with versatile functions
Elias S. J. Arner
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
Andrew G. Cox et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Stratification of breast cancer risk in women with atypia: A Mayo cohort study
Amy C. Degnim et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines
Fang Zhao et al.
CANCER LETTERS (2006)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Benign breast disease and the risk of breast cancer
LC Hartmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers
Q Felty et al.
BIOCHEMISTRY (2005)
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes
S Meiners et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular alterations in sporadic breast cancer
F Lerebours et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span
A Mitsui et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2-terpyridine)platinum(II) complexes.: Possible implications for a novel antitumor strategy
K Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)